Neulasta and Bendeka drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neulasta (pegfilgrastim) and Bendeka (bendamustine hydrochloride). Common drug interactions include dizziness among females and blood pressure decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Neulasta and Bendeka. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Neulasta?

Neulasta has active ingredients of pegfilgrastim. It is often used in agranulocytosis. eHealthMe is studying from 92,286 Neulasta users. Check the latest studies of Neulasta.

What is Bendeka?

Bendeka has active ingredients of bendamustine hydrochloride. eHealthMe is studying from 591 Bendeka users. Check the latest studies of Bendeka.

On Jul, 03, 2026

32 people who take Neulasta and Bendeka together, and have interactions are studied.

What are the common drug interactions of Neulasta and Bendeka, by gender? *:

female:

Dizziness
Abdominal pain
Blood pressure decreased
Dysarthria (speech disorder)
Incoherent (talking in a confused and unclear way)
Nausea (feeling of having an urge to vomit)
Pupil fixed
Respiratory rate decreased (less breathing rate/min)
Vomiting
Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)

male:

Blood pressure decreased
Drug ineffective
Insomnia (sleeplessness)
Lymphocyte count decreased
Mean cell haemoglobin increased (more than normal haemoglobin per red blood cell in a sample of blood)
Mean cell volume increased (more than normal average red blood cell volume)
Platelet count decreased
Rash
Rash pruritic (redness with itching)
Red blood cell count decreased

What are the common drug interactions of Neulasta and Bendeka, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Application site pain
Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

60+:

Blood pressure decreased
Drug ineffective
Insomnia (sleeplessness)
Lymphocyte count decreased
Mean cell haemoglobin increased (more than normal haemoglobin per red blood cell in a sample of blood)
Mean cell volume increased (more than normal average red blood cell volume)
Platelet count decreased
Rash
Rash pruritic (redness with itching)
Red blood cell count decreased

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 8 people, 25.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 6 people, 18.75%
Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 5 people, 15.62%
Lymphoma (cancer that begins in immune system cells): 3 people, 9.38%
Burkitt Lymphoma (cancer of the lymphatic system): 2 people, 6.25%
B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Neulasta and Bendeka?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously